Local

FDA authorizes Pfizer COVID-19 booster shots for ages 5 to 11

The U.S. Food and Drug Administration has authorized emergency use to increase the dose of Pfizer / BioNTech’s COVID-19 vaccine COVID-19 for children 5 to 11 years old at least five months after completing the initial immunization program. Pfizer applied for the EUA in late April. , citing company data showing that a third of vaccines have outgrown omicron vaccines by 36 times in this age group. Many children have been diagnosed with the disease and are being hospitalized, and children may experience long-term side effects, even early infections, “FDA Commissioner Dr. Robert Califf said in a statement. Tuesday. “The FDA authorizes the use of a single dose of Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11 to provide continuous protection against COVID-19. A study by the New York State Department of Health and the U.S. Centers for Disease Control and Prevention found that the effectiveness of two doses of Pfizer vaccine for children ages 5 to 12 was significantly reduced during an omicron ride, falling from 68% to almost 12 % of infection. However, both doses continue to provide protection against more serious illnesses that result in emergency or hospital care. Public health officials are urging Americans to stay up-to-date with the COVID-19 vaccine, including all recommended, as the best way to protect themselves and people with around them. Recent CNN research. CDC data show that for those who were fully vaccinated in February, the risk of dying from COVID-19 was 20 times lower than that of people who were not vaccinated 1. 2 and above. The CDC’s Advisory Committee on Immunization Services will meet on Thursday to discuss COVID-19 immunization enhancers. Although the agenda of the meeting has not been published, a vote is scheduled, according to the Federal Register. Tuesday’s decision means anyone who has reached the age of 5 now deserves at least one percent of the incentive. Moderna also sought FDA approval for a second dose of COVID-19 for anyone 18 years of age or older. above, but no decision has yet been made on this request.

The U.S. Food and Drug Administration has approved emergency use to increase the dose of Pfizer / BioNTech’s COVID-19 vaccine for children ages 5 to 11 at least five months after completing the initial immunization series.

Pfizer applied for the EUA at the end of April, citing company data showing that a third of vaccines have improved omicron vaccines 36 times in the same age group.

“While it is more likely that COVID-19 shows weakness in children than in adults, omicron juice has seen many children suffer from the disease and be hospitalized, and children may experience long-term side effects. time, and even the first. acute disease, “FDA Commissioner Dr. Robert Califf said in another release news Tuesday. “The FDA authorizes the use of a single dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11 to provide continuous protection against COVID-19.

A study from the New York State Department of Health and the US Centers for Disease Control and Prevention found that the effectiveness of two doses of Pfizer vaccine for children ages 5 to 12 was significantly reduced during an omicron ride, falling from 68% to almost 12% on the front. infection. However, both doses continue to provide protection against a serious illness that results in emergency or hospital care.

Public health officials are urging Americans to stay up-to-date on the COVID-19 vaccine, including all recommended, as the best way to protect themselves and the people around them. with them.

A recent CNN study of CDC data showed that for those who were fully vaccinated and upgraded in February, the risk of dying from COVID-19 was 20 times lower than that of people who had not been vaccinated. 12-year-olds.

The CDC’s Advisory Committee on Immunization Services will meet on Thursday to discuss COVID-19 immunization enhancers. Although the meeting agenda has not been published, a vote is scheduled, according to the federal government register.

Tuesday’s decision means anyone who is 5 years old and above now deserves at least one percent of the incentive.

Those aged 50 years and over 12 or older who have certain types of immunizations are eligible for two doses of the vaccine.

Moderna has also asked the FDA for a second release of COVID-19 for anyone 18 years of age and older, but the request has not yet been made.

FDA authorizes Pfizer COVID-19 booster shots for ages 5 to 11 Source link FDA authorizes Pfizer COVID-19 booster shots for ages 5 to 11

Related Articles

Back to top button